Erratum: Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, (14477-14482) DOI: 10.1073/pnas.0606836103);Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 39, 2006, Pages 14477-14482

  Gao, Hui ^a,b,c   Ouyang, Xuesong ^a,b,c   Banach Petrosky, Whitney A ^a   Gerald, William L ^d   Shen, Michael M ^a,b,c   Abate Shen, Cory ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Akt signaling; Androgen independence; MAP kinase signaling; Mouse models of cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; B RAF KINASE; HOMEODOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

ANDROGEN INDEPENDENCE; ANDROGEN INDEPENDENT PROSTATE CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MORTALITY; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE DEPENDENCE; HORMONE RESPONSE; LETHALITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION; STROMA;

EID: 33749254070     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0708142104     Document Type: Erratum

References (37)

1. Hellerstedt BA, Pienta KJ (2002) CA Cancer J Clin 52:154-179.
2. Feldman BJ, Feldman D (2001) Nat Rev Cancer 1:34-45.
3. Heinlein CA, Chang C (2004) Endocr Rev 25:276-308.
4. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL (2004) Nat Med 10:33-39.
5. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP (2001) Proc Natl Acad Sci USA 98:10823-10828.
6. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, et al. (2004) Cancer Res 64:8867-8875.
7. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987) Endocr Rev 8:338-362.
8. Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM (2003) Cancer Res 63:3886-3890.
9. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C (2002) Proc Natl Acad Sci USA 99:2884-2889.
10. Dong JT (2001) Cancer Metastasis Rev 20:173-193.
11. Shen MM, Abate-Shen C (2003) Dev Dyn 228:767-778.
12. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP (2005) Cancer Res 65:1164-1173.
13. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL (2003) Cancer Cell 4:223-238.
14. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C (2002) Cancer Res 62:2999-3004.
15. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, et al. (2003) Cancer Cell 4:209-221.
16. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J (2002) Mol Cell Biol 22:1495-1503.
17. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, et al. (1999) Genes Dev 13:966-977.
18. Paez J, Sellers WR (2003) Cancer Treat Res 115:145-167.
19. Vivanco I, Sawyers CL (2002) Nat Rev Cancer 2:489-501.
20. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI (2002) Clin Cancer Res 8:1168-1171.
21. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA (2001) Oncogene 20:1981-1989.
22. Gioeli D (2005) Clin Sci (London) 108:293-308.
23. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, et al. (2004) Am J Pathol 164:217-227.
24. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C (2004) Proc Natl Acad Sci USA 101:17204-17209.
25. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS (2003) Prostate 57:205-225.
26. Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q, Bikoff R, Ma H, Kantoff PW, Golub TR, et al. (2003) Proc Natl Acad Sci USA 100:7841-7846.
27. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. (2002) Nature 417:949-954.
28. Uzgare AR, Isaacs JT (2004) Cancer Res 64:6190-6199.
29. Huggins C, Hodges CV (1941) Cancer Res 1:293-297.
30. Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL (2004) Cancer Cell 6:517-527.
31. Voeller HJ, Wilding G, Gelmann EP (1991) Mol Endocrinol 5:209-216.
32. Gumerlock PH, Poonamallee UR, Meyers FJ, DeVere White RW (1991) Cancer Res 51:1632-1637.
33. Moul JW, Friedrichs PA, Lance RS, Theune SM, Chang EH (1992) Prostate 20:327-338.
34. Mukherjee R, Bartlett JM, Krishna NS, Underwood MA, Edwards J (2005) Prostate 64:101-107.
35. Arnold JT, Isaacs JT (2002) Endocr Relat Cancer 9:61-73.
36. Chung LW, Baseman A, Assikis V, Zhau HE (2005) J Urol 173:10-20.
37. Kurita T, Wang YZ, Donjacour AA, Zhao C, Lydon JP, O'Malley BW, Isaacs JT, Dahiya R, Cunha GR (2001) Cell Death Differ 8:192-200.